Primary Care’s Role in Skin Cancer Detection

Expert panelists discuss the essential role of primary care in early skin cancer detection, balancing clinical judgment with emerging AI artificial intelligence tools, and more.

Updated COVID-19 Vaccines Are Approved, But Population Restrictions Concern Experts
September 22, 2025

Seniors remain protected along with any adult or child with underlying risk factors for severe disease, but the healthy US population is left with a choice, so far.

Pilot Trial Challenges Routine Steroid Use After Pediatric Anaphylaxis ED Discharge
September 22, 2025

Corticosteroids following resolution of anaphylaxis should be chosen with clear, clinical rationale and reserved for select children, study authors concluded.

Urine-Based Cervical Cancer Screening Evaluated in World's Largest Study
September 22, 2025

The new study, based in China, will validate urine-based genetic methylation testing which concentrates trace amounts of HPV DNA by more than 10,000 times.

FDA Approves Guselkumab as First IL-23 Inhibitor With Fully Subcutaneous Induction Regimen for Ulcerative Colitis
September 22, 2025

FDA approves guselkumab as the first fully subcutaneous IL-23 inhibitor for ulcerative colitis, showing significant clinical benefits in trials.

No Rx Required for COVID-19 Vaccination But ACIP Calls for Better Informed Consent Process
September 22, 2025

The ACIP on September 19 narrowly voted against requiring a prescription to get the shot but urged more detailed discussion of vaccine risks during shared decision making conversations.

GLP-1 RAs May Reduce Risk for Cancer in Adults with Obesity: Daily Dose
September 22, 2025

Your daily dose of the clinical news you may have missed.

Cervical Cancer Screening in Primary Care: A Q&A with Family Physician Ada Stewart, MD
September 19, 2025

Explore essential insights on cervical cancer screening, patient engagement, and innovative self-collection methods this Gynecologic Cancer Awareness Month.

Elinzanetant Update: Phase 3 Findings Published in JAMA with PDUFA Date Set for October 26
September 19, 2025

If approved, the nonhormonal drug could offer an important new option for postmenopausal women seeking alternatives to hormone therapy.

FDA Approves Ruxolitinib for Pediatric Patients Aged 2-11 Years as First Topical JAK Inhibitor for the Age Group
September 19, 2025

Incyte announced the agency's decision, which was based on findings of significant reduction in atopic dermatitis signs and symptoms during the TRuE-AD3 clinical trial.

Physicians Attending Day 1 of ACIP Meeting Said They Need to be Heard
September 19, 2025

Discussions on day 1 focused on the difference between the MMR and MMR+V vaccines, with clinicians calling for inclusion of real-world experience in any ACIP decision.